{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:33:37Z","timestamp":1789756417215,"version":"4.0.1"},"reference-count":132,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T00:00:00Z","timestamp":1538870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Autoimmune hepatitis (AIH) is a severe form of hepatitis resulting in the autoimmune-mediated destruction of the liver parenchyma. Whereas many of the immunopathogenic events have been elucidated and some of the drivers of the disease have been identified, little is known about the aetiology of the disease. There are certain risk factors, such as particular human leucocyte antigen (HLA) haplotypes, that enhance the susceptibility for AIH or influence the severity of the disease. However, as for many other autoimmune diseases, the mere presence of such risk factors does not warrant the occurrence of the disease. Not all individuals carrying risk factors develop AIH, and not all patients with AIH are carriers of high-risk alleles. Thus, additional environmental factors need to be considered as triggers for AIH. Environmental factors include diet, sunlight exposure, stress, medication and hygiene, as well as pathogen infections and vaccinations. This review discusses if pathogens should be considered as triggers for the initiation and\/or propagation of AIH.<\/jats:p>","DOI":"10.1111\/cei.13203","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T11:21:08Z","timestamp":1534418468000},"page":"35-51","source":"Crossref","is-referenced-by-count":44,"title":["Pathogens and autoimmune hepatitis"],"prefix":"10.1093","volume":"195","author":[{"given":"U","family":"Christen","sequence":"first","affiliation":[{"name":"Pharmazentrum Frankfurt \/ ZAFES, Goethe University Hospital, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hintermann","sequence":"additional","affiliation":[{"name":"Pharmazentrum Frankfurt \/ ZAFES, Goethe University Hospital, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,7]]},"reference":[{"key":"2022011418453375900_cei13203-bib-0001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"19","author":"Czaja","year":"2015","journal-title":"Clin Liver Dis"},{"key":"2022011418453375900_cei13203-bib-0002","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0003","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2022011418453375900_cei13203-bib-0004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","article-title":"Cellular and molecular mechanisms of autoimmune hepatitis","volume":"13","author":"Webb","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"2022011418453375900_cei13203-bib-0005","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0006","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.dld.2018.02.015","article-title":"Clinical and prognostic implications of acute onset of autoimmune hepatitis: an Italian multicentre study","volume":"50","author":"Muratori","year":"2018","journal-title":"Dig Liver Dis"},{"key":"2022011418453375900_cei13203-bib-0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cgh.2015.07.017","article-title":"Features and progression of asymptomatic autoimmune hepatitis in Italy","volume":"14","author":"Muratori","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022011418453375900_cei13203-bib-0008","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the international Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0009","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0011","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0012","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/1744666X.2017.1327355","article-title":"Diagnostic approach to autoimmune hepatitis","volume":"13","author":"Muratori","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"2022011418453375900_cei13203-bib-0013","article-title":"Autoantibodies in autoimmune hepatitis: can epitopes tell us about the etiology of the disease?","volume":"163","author":"Christen","year":"2018","journal-title":"Front Immunol"},{"key":"2022011418453375900_cei13203-bib-0014","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","author":"Czaja","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2022011418453375900_cei13203-bib-0015","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","author":"Muratori","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2022011418453375900_cei13203-bib-0016","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"2022011418453375900_cei13203-bib-0018","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0019","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0168-8278(96)80290-X","article-title":"Identification of cyclin a as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases","volume":"25","author":"Strassburg","year":"1996","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0020","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"2022011418453375900_cei13203-bib-0021","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011418453375900_cei13203-bib-0022","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2133\/dmpk.25.84","article-title":"LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6","volume":"25","author":"Komurasaki","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"2022011418453375900_cei13203-bib-0023","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"2022011418453375900_cei13203-bib-0024","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1568-9972(03)00036-3","article-title":"Autoimmunity and hepatitis C","volume":"2","author":"Strassburg","year":"2003","journal-title":"Autoimmun Rev"},{"key":"2022011418453375900_cei13203-bib-0025","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/138161208784746824","article-title":"HCV and autoimmunity","volume":"14","author":"Ferri","year":"2008","journal-title":"Curr Pharm Des"},{"key":"2022011418453375900_cei13203-bib-0026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2008-1040439","article-title":"The asialoglycoprotein receptor as target structure in autoimmune liver diseases","volume":"11","author":"Poralla","year":"1991","journal-title":"Semin Liver Dis"},{"key":"2022011418453375900_cei13203-bib-0027","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u2018Atypical p-ANCA\u2019 in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0028","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"2022011418453375900_cei13203-bib-0029","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1155\/2000\/910107","article-title":"Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases","volume":"14","author":"Obermayer-Straub","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"2022011418453375900_cei13203-bib-0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1081\/DMR-200028798","article-title":"Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2","volume":"37","author":"Mizutani","year":"2005","journal-title":"Drug Metab Rev"},{"key":"2022011418453375900_cei13203-bib-0031","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"14","author":"Vierling","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"2022011418453375900_cei13203-bib-0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.07.021","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases","volume":"450","author":"Villalta","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2022011418453375900_cei13203-bib-0033","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","article-title":"Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques","volume":"187","author":"Muratori","year":"1995","journal-title":"J Immunol Methods"},{"key":"2022011418453375900_cei13203-bib-0034","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2022011418453375900_cei13203-bib-0036","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"European AIHBUCSG. budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0037","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bpg.2011.08.003","article-title":"Therapy of autoimmune hepatitis","volume":"25","author":"Strassburg","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2022011418453375900_cei13203-bib-0038","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10620-012-2151-2","article-title":"Advances in the current treatment of autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"2022011418453375900_cei13203-bib-0039","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0041","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.1840190311","article-title":"Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis","volume":"19","author":"Doherty","year":"1994","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0042","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0043","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"key":"2022011418453375900_cei13203-bib-0044","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2004.02.023","article-title":"Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients","volume":"40","author":"Djilali-Saiah","year":"2004","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0046","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J Autoimmun"},{"key":"2022011418453375900_cei13203-bib-0047","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0048","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","article-title":"Using GWAS to identify genetic predisposition in hepatic autoimmunity","volume":"66","author":"Webb","year":"2016","journal-title":"J Autoimmun"},{"key":"2022011418453375900_cei13203-bib-0049","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bcp.2011.06.023","article-title":"The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling","volume":"82","author":"Devalliere","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"2022011418453375900_cei13203-bib-0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","article-title":"Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis","volume":"31","author":"Agarwal","year":"2000","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0051","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0052","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1399-0039.2006.00794.x","article-title":"A functional fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis","volume":"69","author":"Agarwal","year":"2007","journal-title":"Tissue Antigens"},{"key":"2022011418453375900_cei13203-bib-0053","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis","volume":"30","author":"Cookson","year":"1999","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0054","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/0016-5085(90)91095-N","article-title":"Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis","volume":"98","author":"Czaja","year":"1990","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0055","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0056","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1","volume":"16","author":"vanGerven","year":"2015","journal-title":"Genes Immun"},{"key":"2022011418453375900_cei13203-bib-0057","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0058","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0059","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"2022011418453375900_cei13203-bib-0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/cei.12353","article-title":"Helminths in the hygiene hypothesis: sooner or later?","volume":"177","author":"Maizels","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2022011418453375900_cei13203-bib-0061","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cmi.2010.71","article-title":"Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?","volume":"8","author":"Christen","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"2022011418453375900_cei13203-bib-0062","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrmicro754","article-title":"Microorganisms and autoimmunity: making the barren field fertile","volume":"1","author":"von Herrath","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"2022011418453375900_cei13203-bib-0063","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(02)00222-0","article-title":"Superantigens: microbial agents that corrupt immunity","volume":"2","author":"Llewelyn","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"2022011418453375900_cei13203-bib-0064","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/B978-0-444-56378-1.00004-6","article-title":"Molecular mimiry","volume-title":"Autoantibodies","author":"Christen","year":"2014"},{"key":"2022011418453375900_cei13203-bib-0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"2022011418453375900_cei13203-bib-0066","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/193151a0","article-title":"Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity","volume":"193","author":"Rowley","year":"1962","journal-title":"Nature"},{"key":"2022011418453375900_cei13203-bib-0067","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/282313","article-title":"Molecular mimicry: antigen sharing by parasite and host and its consequences","volume":"98","author":"Damian","year":"1964","journal-title":"Am Nat"},{"key":"2022011418453375900_cei13203-bib-0068","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/jvi.57.1.397-401.1986","article-title":"Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues","volume":"57","author":"Srinivasappa","year":"1986","journal-title":"J Virol"},{"key":"2022011418453375900_cei13203-bib-0069","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain\u2013Barre syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"2022011418453375900_cei13203-bib-0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12265-013-9526-4","article-title":"Identification of streptococcal m-protein cardiopathogenic epitopes in experimental autoimmune valvulitis","volume":"7","author":"Kirvan","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"key":"2022011418453375900_cei13203-bib-0071","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0072","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0140-6736(91)92858-Y","article-title":"Identification of hepatitis a virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals","volume":"337","author":"Vento","year":"1991","journal-title":"Lancet"},{"key":"2022011418453375900_cei13203-bib-0073","first-page":"1","article-title":"Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis","volume":"25","author":"Vento","year":"1988","journal-title":"J Clin Lab Immunol"},{"key":"2022011418453375900_cei13203-bib-0074","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","article-title":"Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case\u2013control study of the Dionysos cohort","volume":"45","author":"Lenzi","year":"1999","journal-title":"Gut"},{"key":"2022011418453375900_cei13203-bib-0075","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.510240309","article-title":"Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa","volume":"24","author":"Gregorio","year":"1996","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0076","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00281-012-0328-6","article-title":"Autoimmune manifestations in viral hepatitis","volume":"35","author":"Vergani","year":"2013","journal-title":"Semin Immunopathol"},{"key":"2022011418453375900_cei13203-bib-0077","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2249.2003.02229.x","article-title":"Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection","volume":"133","author":"Gregorio","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2022011418453375900_cei13203-bib-0078","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3748\/wjg.v16.i29.3704","article-title":"Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis?","volume":"16","author":"Badiani","year":"2010","journal-title":"World J Gastroenterol"},{"key":"2022011418453375900_cei13203-bib-0079","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(99)80092-0","article-title":"Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment","volume":"30","author":"Dalekos","year":"1999","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0080","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1086\/379018","article-title":"Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment","volume":"37","author":"Muratori","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2022011418453375900_cei13203-bib-0081","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1067\/mpd.2003.45","article-title":"Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children","volume":"142","author":"Bortolotti","year":"2003","journal-title":"J Pediatr"},{"key":"2022011418453375900_cei13203-bib-0082","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2009.02.020","article-title":"Clinical features and effect of antiviral therapy on anti-liver\/kidney microsomal antibody type 1 positive chronic hepatitis C","volume":"50","author":"Ferri","year":"2009","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0083","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"2022011418453375900_cei13203-bib-0084","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.20816","article-title":"LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?","volume":"42","author":"Marceau","year":"2005","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0085","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"2022011418453375900_cei13203-bib-0086","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2011.06.005","article-title":"Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model","volume":"37","author":"Hintermann","year":"2011","journal-title":"J Autoimmun"},{"key":"2022011418453375900_cei13203-bib-0087","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0896-8411(91)90180-K","article-title":"Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody","volume":"4","author":"Gueguen","year":"1991","journal-title":"J Autoimmun"},{"key":"2022011418453375900_cei13203-bib-0088","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/jaut.2001.0565","article-title":"Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients","volume":"17","author":"Kitazawa","year":"2001","journal-title":"J Autoimmun"},{"key":"2022011418453375900_cei13203-bib-0089","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"2022011418453375900_cei13203-bib-0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/eji.1830230519","article-title":"Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver\u2013kidney microsome type-1 antibodies (LKM1)","volume":"23","author":"Yamamoto","year":"1993","journal-title":"Eur J Immunol"},{"key":"2022011418453375900_cei13203-bib-0091","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/0016-5085(94)90426-X","article-title":"Primary and secondary liver\/kidney microsomal autoantibody response following infection with hepatitis C virus","volume":"106","author":"Mackie","year":"1994","journal-title":"Gastroenterology"},{"key":"2022011418453375900_cei13203-bib-0092","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-med-052915-015720","article-title":"Oral combination therapies for hepatitis C virus infection: successes, challenges, and unmet needs","volume":"68","author":"Naggie","year":"2017","journal-title":"Annu Rev Med"},{"key":"2022011418453375900_cei13203-bib-0093","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.4049\/jimmunol.0800997","article-title":"Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion","volume":"182","author":"Bucks","year":"2009","journal-title":"J Immunol"},{"key":"2022011418453375900_cei13203-bib-0094","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1073\/pnas.0809818106","article-title":"High antigen levels are the cause of T cell exhaustion during chronic viral infection","volume":"106","author":"Mueller","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"2022011418453375900_cei13203-bib-0095","doi-asserted-by":"crossref","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","article-title":"Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation","volume":"6","author":"Bengsch","year":"2010","journal-title":"PLOS Pathog"},{"key":"2022011418453375900_cei13203-bib-0096","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.0613-17","article-title":"Development of autoimmune hepatitis during direct-acting antiviral therapy for chronic hepatitis C virus infection: a case report","author":"Matsumoto","year":"2018","journal-title":"Intern Med"},{"key":"2022011418453375900_cei13203-bib-0097","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000475752","article-title":"Successful treatment for chronic hepatitis C-autoimmune hepatitis overlap syndrome due to daclatasvir and asunaprevir","volume":"11","author":"Sugiura","year":"2017","journal-title":"Case Rep Gastroenterol"},{"key":"2022011418453375900_cei13203-bib-0098","doi-asserted-by":"crossref","first-page":"987471","DOI":"10.1155\/2012\/987471","article-title":"Epstein\u2013Barr virus as a trigger of autoimmune liver diseases","volume":"2012","author":"Rigopoulou","year":"2012","journal-title":"Adv Virol"},{"key":"2022011418453375900_cei13203-bib-0099","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1665-2681(19)31398-5","article-title":"Autoimmune hepatitis type-2 and Epstein\u2013Barr virus infection in a toddler: art of facts or an artifact?","volume":"12","author":"Zellos","year":"2013","journal-title":"Ann Hepatol"},{"key":"2022011418453375900_cei13203-bib-0100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein\u2013Barr virus in autoimmune diseases","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2022011418453375900_cei13203-bib-0101","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(95)91438-2","article-title":"Epstein\u2013Barr virus as a trigger for autoimmune hepatitis in susceptible individuals","volume":"346","author":"Vento","year":"1995","journal-title":"Lancet"},{"key":"2022011418453375900_cei13203-bib-0102","first-page":"1781","article-title":"Chronic autoimmune hepatitis with Epstein\u2013Barr virus superinfection: a case report and review of literature","volume":"55","author":"Koay","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"2022011418453375900_cei13203-bib-0103","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(95)91932-5","article-title":"A young woman with hepatitis after a sore throat","volume":"346","author":"Aceti","year":"1995","journal-title":"Lancet"},{"key":"2022011418453375900_cei13203-bib-0104","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.inf.0000060825.68086.9c","article-title":"Autoimmune hepatitis type 1 after Epstein\u2013Barr virus infection","volume":"22","author":"Nobili","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"2022011418453375900_cei13203-bib-0105","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s005350050324","article-title":"Epstein\u2013Barr virus infection resembling autoimmune hepatitis with lactate dehydrogenase and alkaline phosphatase anomaly","volume":"34","author":"Kojima","year":"1999","journal-title":"J Gastroenterol"},{"key":"2022011418453375900_cei13203-bib-0106","doi-asserted-by":"crossref","first-page":"bcr0620080071","DOI":"10.1136\/bcr.06.2008.0071","article-title":"Autoimmune hepatitis following Epstein\u2013Barr virus infection","volume":"2008","author":"Cabibi","year":"2008","journal-title":"BMJ Case Rep"},{"key":"2022011418453375900_cei13203-bib-0107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00042737-200402000-00017","article-title":"Fatal chronic active Epstein\u2013Barr virus infection mimicking autoimmune hepatitis","volume":"16","author":"Chiba","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022011418453375900_cei13203-bib-0108","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jmv.1890120406","article-title":"Measles virus-specific IgM antibodies in sera from patients with chronic active hepatitis","volume":"12","author":"Christie","year":"1983","journal-title":"J Med Virol"},{"key":"2022011418453375900_cei13203-bib-0109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(87)93051-0","article-title":"Persistent measles virus genome in autoimmune chronic active hepatitis","volume":"2","author":"Robertson","year":"1987","journal-title":"Lancet"},{"key":"2022011418453375900_cei13203-bib-0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(89)90940-9","article-title":"Measles and autoimmune chronic active hepatitis","volume":"2","author":"Mieli-Vergani","year":"1989","journal-title":"Lancet"},{"key":"2022011418453375900_cei13203-bib-0111","first-page":"2618","article-title":"Autoimmune hepatitis type 1 after measles","volume":"91","author":"Vento","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"2022011418453375900_cei13203-bib-0112","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3748\/wjg.15.1004","article-title":"Severe autoimmune hepatitis triggered by varicella zoster infection","volume":"15","author":"Al-Hamoudi","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2022011418453375900_cei13203-bib-0113","first-page":"397","article-title":"Association of an overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis with cytomegalovirus infection","volume":"4","author":"Toyoda-Akui","year":"2011","journal-title":"Int J Gen Med"},{"key":"2022011418453375900_cei13203-bib-0114","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1258\/ijsa.2009.009337","article-title":"Autoimmune hepatitis in an HIV-infected patient: an intriguing association","volume":"23","author":"Hagel","year":"2012","journal-title":"Int J STD AIDS"},{"key":"2022011418453375900_cei13203-bib-0115","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fimmu.2018.00811","article-title":"Treatment intensification in HIV-infected patients is associated with reduced frequencies of regulatory T cells","volume":"9","author":"Grutzner","year":"2018","journal-title":"Front Immunol"},{"key":"2022011418453375900_cei13203-bib-0116","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3347\/kjp.2012.50.2.133","article-title":"Visceral leishmaniasis mimicking autoimmune hepatitis, primary biliary cirrhosis, and systemic lupus erythematosus overlap","volume":"50","author":"Tunccan","year":"2012","journal-title":"Korean J Parasitol"},{"key":"2022011418453375900_cei13203-bib-0117","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-2249.1999.01027.x","article-title":"Overlapping but distinct specificities of anti-liver\u2013kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes","volume":"118","author":"Klein","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2022011418453375900_cei13203-bib-0118","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193\u2013212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J Immunol"},{"key":"2022011418453375900_cei13203-bib-0119","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1248\/bpb.28.2240","article-title":"A new epitope of CYP2D6 recognized by liver kidney microsomal autoantibody from japanese patients with autoimmune hepatitis","volume":"28","author":"Imaoka","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"2022011418453375900_cei13203-bib-0120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/0891693021000069556","article-title":"A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens","volume":"35","author":"Sugimura","year":"2002","journal-title":"Autoimmunity"},{"key":"2022011418453375900_cei13203-bib-0121","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/039463200401700112","article-title":"Multiple viral\/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51","volume":"17","author":"Bogdanos","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2022011418453375900_cei13203-bib-0122","first-page":"1","article-title":"The CYP2D6 animal model: how to induce autoimmune hepatitis in mice","volume":"60","author":"Hintermann","year":"2012","journal-title":"J Vis Exp"},{"key":"2022011418453375900_cei13203-bib-0123","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2013.05.001","article-title":"Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6","volume":"44","author":"Hintermann","year":"2013","journal-title":"J Autoimmun"},{"key":"2022011418453375900_cei13203-bib-0124","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","volume":"42","author":"Ehser","year":"2013","journal-title":"J Autoimmun"},{"key":"2022011418453375900_cei13203-bib-0125","article-title":"Animal models of autoimmune hepatitis","author":"Christen","year":"2018","journal-title":"Biochim Biophis Acta"},{"key":"2022011418453375900_cei13203-bib-0126","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.1991.tb08164.x","article-title":"Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis","volume":"84","author":"Lohr","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011418453375900_cei13203-bib-0127","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.510240619","article-title":"Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis","volume":"24","author":"Lohr","year":"1996","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.169.1.277","article-title":"Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule","volume":"169","author":"Ma","year":"2002","journal-title":"J Immunol"},{"key":"2022011418453375900_cei13203-bib-0129","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatology"},{"key":"2022011418453375900_cei13203-bib-0130","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.165.5.2415","article-title":"Break of T cell ignorance to a viral antigen in the liver induces hepatitis","volume":"165","author":"Voehringer","year":"2000","journal-title":"J Immunol"},{"key":"2022011418453375900_cei13203-bib-0131","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D","article-title":"Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment","volume":"28","author":"Limmer","year":"1998","journal-title":"Eur J Immunol"},{"key":"2022011418453375900_cei13203-bib-0132","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1568-9972(03)00053-3","article-title":"Is there a role for viruses in triggering autoimmune hepatitis?","volume":"3","author":"Vento","year":"2004","journal-title":"Autoimmun Rev"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13203","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/195\/1\/35\/42197176\/cei13203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/195\/1\/35\/42197176\/cei13203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T20:15:33Z","timestamp":1642191333000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/195\/1\/35\/6403593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,7]]},"references-count":132,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,7]]},"published-print":{"date-parts":[[2018,12,19]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13203","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,10,7]]}}}